Antibodies directed against AQP-4 are characteristically found in patients suffering from neuromyelitis optica (NMO), a demyelinating disease of the CNS that mainly affects the optic nerve and the spinal cord [44]. The gene discussed is AQP4; the disease is demyelinating disease of central nervous system.